Home
Diseases
Asthma
Clinical Trials

Clinical Trials Related to Asthma

Related studies linked through entity extraction aliases.

A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients.

Status: COMPLETED
Phase: PHASE2

Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

Status: COMPLETED
Phase: PHASE2

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

Status: COMPLETED
Phase: PHASE2

Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics

Status: COMPLETED
Phase: PHASE1/PHASE2

Effects of Green Tea Extract (GTE) on Systemic Oxidative and Antioxidative Status in Chinese Patients With Stable Asthma

Status: COMPLETED
Phase: NA

A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)

Status: COMPLETED
Phase: N/A

Dietary Interventions in Asthma Treatment: Sprouts Study

Status: TERMINATED
Phase: NA

Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma

Status: COMPLETED
Phase: PHASE3

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

Status: COMPLETED
Phase: PHASE1

Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients

Status: COMPLETED
Phase: PHASE1/PHASE2

School-Based Preventive Asthma Care Technology: A Trial Using a Novel Technology to Improve Adherence

Status: COMPLETED
Phase: NA

School-based Asthma Therapy: Stage 2 Effectiveness Study

Status: COMPLETED
Phase: NA

Clinical, Airway Inflammatory, and HRA Phenotypes, in Preschool Children With Acute Asthmatic Attack Presenting to the ED.

Status: COMPLETED
Phase: N/A

Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

Status: COMPLETED
Phase: PHASE2

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

Status: COMPLETED
Phase: PHASE3

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I

Status: COMPLETED
Phase: PHASE3

Small Particle Steroids in Refractory Asthma

Status: COMPLETED
Phase: PHASE4

Promoting Asthma Wellness in Rural Communities

Status: COMPLETED
Phase: NA

Coping Peer Intervention for Adherence

Status: COMPLETED
Phase: NA

Improving Asthma Outcomes Through Spirometry Distance Learning

Status: COMPLETED
Phase: NA